Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/002287 stock hub

SHE/002287 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002287is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002287

In the news

Latest news · SHE/002287

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E19

P25 23.5P50 41.3P75 83.2

ROE14.6

P25 -0.9P50 4.1P75 8.8

ROIC20.5

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002287 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

CNY

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	3,170
Employees Change	79%
Employees Change Percent	2.56
Enterprise value	CNY 11.2B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100000FM9
Last refreshed	2026-05-10
Market cap	CNY 13B
Price	CNY 23.01
Price currency	CNY
Rev Per Employee	762,854.77x
Sector	Healthcare
Sic	2834
Symbol	she/002287
Website	https://www.cheezheng.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.12%
EV Earnings	16.83x
EV/EBIT	15.48x
EV/EBITDA	12.94x
EV/FCF	60.66x
EV/Sales	4.65x
FCF yield	1.42%
P/B ratio	2.56x
P/E ratio	19.03x
P/S ratio	5.39x
PE Ratio10 Y	31.83x
PE Ratio3 Y	21.14x
PE Ratio5 Y	21.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.03%
EBITDA Margin	35.92%
FCF margin	7.66%
Gross margin	83.45%
Gross Profit	CNY 2B
Gross Profit Growth	3.44%
Gross Profit Growth Q	3.52%
Gross Profit Growth3 Y	7.81%
Gross Profit Growth5 Y	7.26%
Net Income	CNY 667.9M
Net Income Growth	19.17%
Net Income Growth Q	25.77%
Net Income Growth Quarters	2%
Net Income Growth Years	3%
Net Income Growth3 Y	11.78%
Net Income Growth5 Y	7.82%
Pretax Margin	31.42%
Profit Margin	27.62%
Profit Per Employee	CNY 210,702
Profitable Years	20
ROA	6.79
Roa5y	5.5
ROCE	13.57
ROE	14.55
Roe5y	16.73
ROIC	20.49
Roic5y	17.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.08%
Cagr15y	3.47%
Cagr1y	-2.45%
Cagr3y	0.52%
Cagr5y	1.42%
Div CAGR10	10.59%
Div CAGR3	11.6%
Div CAGR5	18.56%
EPS Growth	14.46
EPS Growth Q	17.97
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	10.29
EPS Growth5 Y	6.93
FCF Growth	-71.37%
OCF Growth	-65.66%
OCF Growth10 Y	3.37%
OCF Growth3 Y	48.47%
OCF Growth5 Y	45.15%
Revenue Growth	1.78x
Revenue Growth Q	0.56x
Revenue Growth Quarters	2x
Revenue Growth Years	9x
Revenue Growth3 Y	7.75x
Revenue Growth5 Y	7.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.36
Assets	CNY 6.7B
Cash	CNY 2.7B
Current Assets	CNY 4.1B
Current Liabilities	CNY 1.3B
Debt	CNY 807.8M
Debt EBITDA	CNY 0.93
Debt Equity	CNY 0.16
Debt FCF	CNY 4.36
Equity	CNY 5.1B
Liabilities	CNY 1.6B
Long Term Assets	CNY 2.6B
Long Term Liabilities	CNY 263.4M
Net Cash	CNY 1.8B
Net Cash By Market Cap	CNY 14.16
Net Cash Growth	33.02%
Net Debt EBITDA	CNY -2.13
Net Debt Equity	CNY -0.36
Net Debt FCF	CNY -9.97
Tangible Book Value	CNY 4.7B
Tangible Book Value Per Share	CNY 8.38
WACC	5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.12
Inventory Turnover	1.43
Net Working Capital	CNY 883M
Quick ratio	2.71
Working Capital	CNY 2.8B
Working Capital Turnover	CNY 0.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.12%
Dividend Growth	0%
Dividend Growth Years	2%
Dividend per share	CNY 0.44
Dividend Years	16
Dividend Yield	1.91%
Last Dividend	CNY 0.22
Payout Ratio	50.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-0.81%
1Y total return	-2.45%
200-day SMA	25.25
3Y total return	1.58%
50-day SMA	23.58
50-day SMA vs 200-day SMA	50under200
5Y total return	7.33%
All Time High	50.3
All Time High Change	-54.25%
All Time High Date	2016-11-22
All Time Low	9.41
All Time Low Change	144.48%
All Time Low Date	2012-12-04
ATR	0.36
Beta	0.19
Beta1y	-0.32
Beta2y	0
Ch YTD	-2.75
High	23.18
High52	38.16
High52 Date	2025-08-04
High52ch	-39.7%
Low	22.88
Low52	21.8
Low52 Date	2025-06-18
Low52ch	5.55%
Ma50ch	-2.4%
Price vs 200-day SMA	-8.88%
RSI	47.7
RSI Monthly	47.73
RSI Weekly	42.34
Sharpe ratio	-0.07x
Sortino ratio	0.07
Total Return	-2.2%
Tr YTD	-2.75
Tr15y	66.88%
Tr1m	-0.86%
Tr1w	0.79%
Tr3m	-8.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 726.3M
Operating Income Growth	16.41
Operating Income Growth Q	-0.12
Operating Income Growth3 Y	19.29
Operating Income Growth5 Y	11.81
Operating margin	30.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	105,284,157%
Net Borrowing	-188,336,474
Shares Insiders	0.11%
Shares Institutions	1%
Shares Out	566,878,308
Shares Qo Q	-0.36%
Shares Yo Y	4.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 185.4M
Average Volume	1,755,718.4x
Bv Per Share	8.9
CAPEX	CNY -125.1M
Ch10y	-17.02
Ch15y	29.89
Ch1m	-0.86
Ch1w	0.79
Ch1y	-4.88
Ch3m	-8.4
Ch3y	-5.97
Ch5y	-4.24
Ch6m	-9.19
Change	0.17%
Change From Open	-0.35
Close	22.97
Days Gap	0.52
Depreciation Amortization	142,414,826
Dollar Volume	42,942,504.5
Earnings Date	2026-04-24
EBIT	CNY 726.3M
EBITDA	CNY 868.7M
EPS	CNY 1.21
F Score	7
FCF	CNY 185.4M
FCF EV Yield	1.65x
FCF Per Share	CNY 0.33
Financing CF	-668,069,731
Fiscal Year End	December
Founded	1,995
Graham Number	15.56553
Graham Upside	-32.35
Income Tax	CNY 93.5M
Investing CF	-9,516,710
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2019-07-11
Last Split Type	Forward
Lynch Fair Value	CNY 9.46
Lynch Upside	-58.9
Ma150	24.56
Ma150ch	-6.29%
Ma20	23.05
Ma20ch	-0.16%
Net CF	-367,345,175
Open	23.09
P FCF Ratio	70.37
P OCF Ratio	42.02
Payment Date	2025-09-22
Position In Range	43.33
Ppne	1,686,360,418
Price Date	2026-05-08
Price EBITDA	CNY 15.01
Ptbv Ratio	2.75
Relative Volume	1.08x
Revenue	2,418,249,608x
Tax By Revenue	3.87x
Tax Rate	12.31%
Tr6m	-9.19%
Volume	1,866,254

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002287 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$0.44 annual per share

Payout ratio

+50.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+18.6%

2 consecutive years of growth

Total shareholder yield

-2.2%

Dividend yield + buyback yield combined

Performance

SHE/002287 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002287?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.1%

Negative means the company is buying back shares.

Technical

SHE/002287 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.7

Neutral momentum band

Price vs 200-day MA

-8.9%

50/200-day relationship not available

Beta (5Y)

0.19

Less volatile than the market

Sharpe ratio

-0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002287

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002287 stock rating?

she/002287 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002287 analysis?

The full report lives at /stocks/she/002287/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002287?

The latest report frames she/002287 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002287 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.